01781nam 2200553Ia 450 991079003340332120200520144314.01-61122-106-4(CKB)2670000000092421(EBL)3018653(SSID)ssj0000522641(PQKBManifestationID)12230624(PQKBTitleCode)TC0000522641(PQKBWorkID)10538723(PQKB)10487535(MiAaPQ)EBC3018653(Au-PeEL)EBL3018653(CaPaEBR)ebr10661591(OCoLC)726743266(EXLCZ)99267000000009242120100812d2011 uy 0engur|n|---|||||txtccrFlax lipids[electronic resource] classes, biosynthesis, genetics and the promise of applied genomics for understanding and altering of fatty acids /Bourlaye Fofana, Sylvie Cloutier, and Raja RagupathyNew York Nova Science Publishersc20111 online resource (59 p.)Biotechnology in agriculture, industry and medicineDescription based upon print version of record.1-61761-470-X Includes bibliographical references (p. [31]-43) and index.Biotechnology in Agriculture, Industry and MedicineFlaxLinseed oilFlax.Linseed oil.633.8/5Fofana Bourlaye1541766Cloutier Sylvie1541767Ragupathy Raja1541768MiAaPQMiAaPQMiAaPQBOOK9910790033403321Flax lipids3794130UNINA03490nam 22006492 450 991078296830332120151005020623.01-107-11115-31-280-15888-397866101588810-511-11716-70-511-00597-00-511-14908-50-511-30292-40-511-54416-20-511-05128-X(CKB)1000000000003511(EBL)144648(OCoLC)437072460(SSID)ssj0000166469(PQKBManifestationID)11164924(PQKBTitleCode)TC0000166469(PQKBWorkID)10161514(PQKB)11046298(UkCbUP)CR9780511544163(MiAaPQ)EBC144648(Au-PeEL)EBL144648(CaPaEBR)ebr2000719(CaONFJC)MIL15888(PPN)261332384(EXLCZ)99100000000000351120090506d1999|||| uy| 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierA guide to the extrapyramidal side-effects of antipsychotic drugs /D.G. Cunningham Owens[electronic resource]Cambridge :Cambridge University Press,1999.1 online resource (x, 351 pages) digital, PDF file(s)Title from publisher's bibliographic system (viewed on 05 Oct 2015).0-521-63353-2 Includes bibliographical references (p. 320-345) and index.Preliminaries; Contents; Preface; 1 The background; 2 Some preliminaries; 3 Acute dystonias; 4 Parkinsonism; 5 Akathisia; 6 Tardive dyskinesia; 7 Tardive and chronic dystonia; 8 Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 9 Special populations; 10 The clinical examination; 11 An overview of some standardised recording instruments; 12 Some medicolegal and quality-of-care issues; References; IndexAntipsychotic drugs have revolutionised the management of major psychiatric disorders and the outcomes of those who suffer from them. They are, however, possessed of a range of adverse effects, amongst the most frequent and distressing of which are those resulting in disturbance of voluntary motor function. Extrapyramidal side effects - or E.P.S. - are still poorly recognised and not infrequently misattributed. Despite a vast research literature, there have been few attempts to bring together both the descriptive clinical elements of these disorders and major research conclusions pertinent to routine practice. This very readable and well illustrated 1999 book seeks to rectify this in the hope of increasing clinicians' awareness of the issues and acknowledgement of their impact. This is a task made more rather than less urgent with the emergence of drugs of lower liability but which may promote subtler abnormality than standard compounds.Extrapyramidal disordersAntipsychotic drugsSide effectsExtrapyramidal disorders.Antipsychotic drugsSide effects.616.8/3Owens D. G. Cunningham(David Griffith Cunningham),1949-1498000UkCbUPUkCbUPBOOK9910782968303321A guide to the extrapyramidal side-effects of antipsychotic drugs3723356UNINA